Insulinoma-released Exosomes Activate Autoreactive Marginal Zone-like B Cells That Expand Endogenously in Prediabetic NOD Mice
Overview
Affiliations
Exosomes (EXOs) are nano-sized secreted microvesicles that can function as potent endogenous carriers of adjuvant and antigens. To examine a possible role in autoimmunity for EXOs, we studied EXO-induced immune responses in nonobese diabetic (NOD) mice, an autoimmune-prone strain with tissue-specific targeting at insulin-secreting beta cells. EXOs released by insulinoma cells can activate various antigen-presenting cells to secrete several proinflammatory cytokines and chemokines. A subset of B cells responded to EXO stimulation in culture by proliferation, and expressed surface markers representing marginal zone B cells, which was independent of T helper cells. Importantly, splenic B cells from prediabetic NOD mice, but not diabetic-resistant mice, exhibited increased reactivity to EXOs, which was correlated with a high level of serum EXOs. We found that MyD88-mediated innate TLR signals were essential for the B-cell response; transgenic B cells expressing surface immunoglobulin specific for insulin reacted to EXO stimulation, and addition of a calcineurin inhibitor FK506 abrogated the EXO-induced B-cell response, suggesting that both innate and antigen-specific signals may be involved. Thus, EXOs may contribute to the development of autoimmunity and type 1 diabetes in NOD mice, partially via activating autoreactive marginal zone-like B cells.
Yu C, Yang C, Chang T, Lan K, Liu S Arch Toxicol. 2024; 98(11):3885-3896.
PMID: 39127846 DOI: 10.1007/s00204-024-03838-8.
How does exosome cause diabetes?.
Hu F, Yu Y, Xu H Hormones (Athens). 2024; 23(3):385-393.
PMID: 38233729 DOI: 10.1007/s42000-024-00525-2.
Exosomes; a Potential Source of Biomarkers, Therapy, and Cure for Type-1 Diabetes.
Lakey J, Wang Y, Alexander M, Chan M, Wong M, Casazza K Int J Mol Sci. 2023; 24(21).
PMID: 37958696 PMC: 10647572. DOI: 10.3390/ijms242115713.
Sustained high glucose intake accelerates type 1 diabetes in NOD mice.
Li X, Wang L, Meng G, Chen X, Yang S, Zhang M Front Endocrinol (Lausanne). 2022; 13:1037822.
PMID: 36545340 PMC: 9760976. DOI: 10.3389/fendo.2022.1037822.
Extracellular vesicles as personalized medicine.
Beetler D, Di Florio D, Bruno K, Ikezu T, March K, Cooper Jr L Mol Aspects Med. 2022; 91:101155.
PMID: 36456416 PMC: 10073244. DOI: 10.1016/j.mam.2022.101155.